Communities across Australia rely on Registered Nurses (RNs) to provide primary care, acute care and aged care. They are skilled, capable and trusted healthcare practitioners often working in some of the most rural and remote parts of the country.
In March 2023, the Australian Government released the National Rural and Remote Nursing Generalist Framework 2023–2027. The Framework is a world first and describes the unique context of practice and core capabilities for rural and remote Registered Nurses in Australia.
As well as describing skills, capabilities and support needed by RNs, the Framework emphasises the importance of clinical decision-making judgement of the patient’s situation, culturally safe practice, collaboration, and partnerships with clients, families and communities.
The framework is for RNs who work in rural and remote locations across Australia, or are looking to relocate there. One such nurse who relocated is Clinton Archer, with Queensland Health, who was interviewed by Australian Health Journal for this segment.
Other ways the the Framework can be applied include:
- For Registered Nurses, mapping their development of the capabilities with a mentor, to develop from formative to proficient skill levels.
- For Educators and Education Providers, supporting individual skill development or curriculum based on the capabilities.
- Government, Organisations and Employers, using the Framework as a guide to grow and support the development of a skilled rural and remote RN workforce
The Framework was developed by the Office of the National Rural Health Commissioner and Australian Health Journal spoke with National Rural Health Commissioner, Adjunct Professor Ruth Stewart, and Deputy National Rural Health Commissioner – Nursing and Midwifery, Adjunct Professor Shelley Nowlan, on the importance of rural and remote nursing and of the Framework itself.
Important contributions and expertise of the members of the National Rural and Remote Nursing Generalist Framework Steering Committee (Steering Committee) led the Framework through its development and consultation. Steering Committee members represented the following organisations.
- Office of the National Rural Health Commissioner
- Australian Government Department of Health and Aged Care
- Australian and New Zealand Council of Chief Nursing and Midwifery Officers
- Australian College of Nurse Practitioners (ACNP)
- Australian College of Nursing (ACN)
- Australian Nursing and Midwifery Accreditation Council (ANMAC)
- Australian Nursing and Midwifery Federation (ANMF)
- Australian Primary Health Care Nurses Association (APNA)
- Congress of Aboriginal and Torres Strait Islander Nurses and Midwives (CATSINaM)
- Council of Deans of Nursing and Midwifery (CDNM)
- Council of Remote Area Nurses of Australia (CRANAplus)
- James Cook University
- Nursing and Midwifery Board of Australia (NMBA)
-
Rapid trend shift in radiology technology and accessibility
Dr Mansoor Parker obtained his medical degree from the University of Tasmania. He then completed his specialist radiology training at Nepean Hospital, Sydney with subspecialty interests in Interventional Radiology and Pain Management, Musculoskeletal, Cardiac and Abdominal Imaging. Dr Parker is a qualified specialist since 2005 and is a member of the Royal Australian and New Zealand College of Radiologists and the exclusive Australasian Musculoskeletal Imaging Group (AMSIG) as well as the Interventional Radiology Society of Australasia (IRSA).
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
